VAMSI LABS LTD (India) holds 10 active US FDA Type II Drug Master Files and 9 inactive, has DMF or CEP filings on record for 16 active ingredients and is linked to 1 FDA-registered manufacturing site. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “VAMSI LABS LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/vamsi-labs-ltd

Overview

VAMSI LABS LTD is an active pharmaceutical ingredient (API) supplier with 7 active FDA Type II Drug Master Files, covering ALBUTEROL SULFATE USP; FLUTICASONE PROPIONATE USP; FORMOTEROL FUMARATE DIHYDRATE USP; HALOPERIDOL USP; LOPERAMIDE HYDROCHLORIDE USP; TIOTROPIUM BROMIDE MONOHYDRATE.

Core services & business areas

API Manufacturing

Active ingredients with DMF or CEP filings

Substances for which VAMSI LABS LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

VAMSI LABS LTD holds 10 active (19 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • GLYCOPYRROLATE USPActive2026-08-10
  • HALOPERIDOL DECANOATE USPActive2026-04-13
  • BUDESONIDE USPActive2026-04-03
  • TRIAMCINOLONE ACETONIDE USPActive2026-03-11
  • FLUTICASONE PROPIONATE USPActive2025-11-25
  • ALBUTEROL SULFATE USPActive2025-11-22
  • FORMOTEROL FUMARATE DIHYDRATE USPActive2025-11-01
  • LOPERAMIDE HYDROCHLORIDE USPActive2025-09-16
  • TIOTROPIUM BROMIDE MONOHYDRATEActive2020-04-15
  • HALOPERIDOL USPActive2019-11-14
  • SALBUTAMOL SULFATE- EPInactive2024-09-30
  • CYPROHEPTADINE HYDROCHLORIDE- EPInactive2024-09-30
  • FENOTEROL HYDROBROMIDE-EPInactive2024-09-26
  • FORMOTEROL FUMARATE DIHYDRATE EPInactive2024-08-31
  • IPRATROPIUM BROMIDE-EPInactive2024-08-28
  • FLUTICASONE FUROATE EPInactive2024-08-26
  • FLUTICASONE PROPIONATE EPInactive2024-08-13
  • SALMETEROL XINAFOATE EPInactive2024-08-13
  • CLENBUTEROL HYDROCHLORIDE EPInactive2024-08-06

Registered manufacturing sites (1)

Physical sites registered with the US FDA and resolved to VAMSI LABS LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to VAMSI LABS LTD in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this VAMSI LABS LTD?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.